WHO
REGULATORY UPDATE
Renata’s Ethinylestradiol/Levonorgestrel 30µg/150µg Tablet, with Ferrous Fumarate Tablet prequalified
Published: 5/11/2026Detected: 4/10/2026
Summary preview
Adds a new WHO Prequalification (PQ) product entry (RH108) for an ethinylestradiol/levonorgestrel 30µg/150µg sugar-coated tablet combined with ferrous fumarate 75 mg tablet by Renata PLC in Bangladesh.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accounthematology
pediatrics
#WHO prequalification
#RH108
#ethinylestradiol/levonorgestrel
#ferrous fumarate
#oral contraceptive
Official Source Document Source Verified
Access the original document directly from WHO.